Mode
Text Size
Log in / Sign up

Host factors influence viral entry and replication in HPIV infected infants, elderly, and immunocompromised individuals

Host factors influence viral entry and replication in HPIV infected infants, elderly, and…
Photo by National Institute of Allergy and Infectious Diseases / Unsplash
Key Takeaway
Consider host-directed therapies for human parainfluenza virus infections in vulnerable populations.

This narrative review examines host factors influencing viral entry, replication, assembly, release, and innate immunity evasion in human parainfluenza virus infected individuals. The scope of the discussion includes infants, the elderly, immunocompromised individuals, and children under five. The review does not report a specific sample size or setting. The authors focus on the biological mechanisms rather than clinical trial data or adverse events. The publication type is a review, not a primary study. The authors do not provide specific outcome data or p-values. The review aims to accelerate the development of innovative host-directed therapies. This approach targets the underlying biological processes of the virus. The text does not make causal claims about specific interventions. The limitations of the review are not explicitly detailed in the provided text. The practice relevance is to accelerate the development of innovative host-directed therapies. The review avoids overstatement of certainty regarding the efficacy of these therapies.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Human parainfluenza viruses (HPIVs)are significant pathogens responsible for acute respiratory infections in infants, the elderly, and immunocompromised individuals. Among children under five, HPIVs are the second most common viral cause of acute lower respiratory tract infections (ALRIs), surpassed only by respiratory syncytial virus (RSV). Despite their significant health impact, there are currently no licensed vaccines or specific antiviral treatments for HPIV infection. Recent advances in functional genomics, including CRISPR-Cas9 screening, cDNA library screening, and multi-omics approaches, have enabled the systematic identification of host factors essential at different stages of HPIVs infections. This review aims to systematically summarize the latest evidence on host factors that influence viral entry, replication, assembly, and release, as well as those involved in evasion of innate immunity. Importantly, we contextualize the mechanisms of these host factors within the broader network of virus-host interactions. By integrating these insights, we aim to provide a strong mechanistic foundation for understanding HPIV pathogenesis to accelerate the development of innovative host-directed therapies(HDTs).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.